Loading...
XJPX
3139
Market cap221mUSD
Dec 05, Last price  
3,455.00JPY
1D
0.88%
1Q
-16.65%
Jan 2017
336.79%
IPO
334.59%
Name

Lacto Japan Co Ltd

Chart & Performance

D1W1MN
XJPX:3139 chart
P/E
10.95
P/S
0.20
EPS
315.51
Div Yield, %
2.20%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
7.91%
Revenues
170.91b
+7.94%
75,942,000,00096,549,538,00098,000,747,00088,679,047,000101,334,802,000115,440,661,000116,794,379,000110,837,536,000110,883,524,000147,423,378,000158,328,290,000170,907,000,000
Net income
3.15b
+53.57%
1,007,000,000988,238,000831,404,000946,443,0001,755,197,0001,784,201,0001,963,038,0002,062,180,0001,959,126,0002,286,794,0002,048,589,0003,146,000,000
CFO
636m
-80.26%
0-4,062,030,0002,535,027,0003,560,354,000-5,048,488,000356,344,0003,365,480,0004,534,014,000-4,037,253,000-10,408,446,0003,222,692,000636,000,000
Dividend
Nov 27, 202582 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lacto Japan Co., Ltd. engages in sourcing and selling dairy ingredients, cheese products, processed meat, and other products in Japan and internationally. The company's products include full cream milk powder, skimmed milk powder, butter, cream, whey powder, whey protein concentrate, casein, caseinate, ice cream, and lactose products; and cheeses, prepared milk powder mixtures, prepared butter mixtures, and other prepared dairy mixtures, as well as liquor, processed eggs, processed meat products, and fresh meat products. It is also involved in the trade of agricultural and livestock products, processed products, food additives, food processing machinery, pharmaceuticals, quasi-pharmaceuticals, beverages, and food products; and provision of agency, brokerage, and consultant services, as well as insurance agency services. The company serves food manufacturers, wholesalers, and retailers. Lacto Japan Co., Ltd. was founded in 1998 and is headquartered in Tokyo, Japan.
IPO date
Aug 28, 2015
Employees
364
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑112023‑112022‑112021‑112020‑112019‑112018‑112017‑112016‑11
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT